Sunday, July 16, 2006

Important Safety Information: Intracranial Hemorrhage in Patients Receiving Aptivus® (tipranavir) Capsules

From Health Canada:
...As of June 7, 2006, Boehringer Ingelheim (BI) has received 14 reports of intracranial hemorrhage (ICH), including 8 fatalities, in 6840 HIV-1 infected patients receiving APTIVUS in clinical trials...

for the Public
for Health Professionals

No comments: